To investigate the effects of Compound Glycyrrhizin Injection (CGI) on liver function and cellular immunity of children with infectious mononucleosis complicated liver impairment (IM-LI) and to explore its clinical therapeutic effect.
Forty-two patients with IM-LI were randomly assigned, according to the randomizing number table, to two groups, 20 in the control group and 22 in the treated group. All the patients were treated with conventional treatment, but to those in the treated group, CGI was given additionally once a day, at the dosage of 10 ml for children aged below 2 years, 20 ml for 2–4 years old, 30 ml for 5–7 years old and 40 ml for 8–12 years old, in 100–200 ml of 5% glucose solution by intravenous dripping. The treatment lasted for 2 weeks. T lymphocyte subsets and serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBil) were detected before and after treatment. Besides, a normal control group consisting of 20 healthy children was also set up.
Baseline of the percentage of CD3 +, CD8 + lymphocyte and serum levels of ALT, AST, TBiL in the children with IM-LI were markedly higher, while the percentage of CD4 + lymphocyte and the CD4 +/CD8 + ratio was markedly lower in IM-LI children as compared with the corresponding indices in the healthy children (P<0.01). These indices were improved after treatment in both groups of patients, but the improvement in the treated group was better than that in the control group (P<0.01).
Cellular immunity dysfunction often occurs in patients with IM-LI, and CGI treatment can not only obviously promote the recovery of liver function, but also regulate the immune function in organism.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Tan ZY, Yu MX, Fu CJ, et al. Diagnosis of infectious mononucleosis in children. Guangdong Med J 2000;21(1): 45–46.
Chen H, Yang JJ. A study on the change of immunity in children with infectious mononucleosis. J Clin Res 2005;22(5): 600–601.
Yu SC, Zhu LF, Shi XP, et al. Dynamic observation of the immunity function of the children with infectious mononucleosis. Modern Prevent Med 2004;31(4): 527–528.
Hu YM, Jiang ZF, editors. Practical pediatrics. 7th ed. Beijing: People’s Medical Publishing House, 2002: 824.
Zhang ZN, editor. Diagnosis and therapeutic criteria of hemorrheology. Beijing: Science Press, 1998: 252–258.
Yang XQ, Yi ZW, editors. Pediatrics. 6th ed. Beijing: People’s Medical Publishing House, 2004: 223–226.
Jia QR, Zhang HY, Li XF, editors. Leukocytic disease. Beijing: Science-technology Literature Publishing House, 2002: 277.
Zhou YF, Jiang LR, Wang W, et al. Study on the dynamic changes of T lymphocyte subsets in children with infectious mononucleosis and infectious mononucleosis-like syndrome. J Clin Pediatr 2003;21(8): 458–460.
Wang XL. Epstein-Barr virus infection and related diseases. Foreign Med Sci (Sect Pediatr) 2005;32(5): 287–290.
Kimura M, Watanabe H, Abo T. Selective activation of extrathymic T cells in the liver by glycyrrhizin. Biotherapy 1992:5(3): 167–176.
Song FW, Li XJ, Jiang YS. Changes of liver pathology with stronger neo-minophagen (SNMC). Chin J Modern Med 2001;11(11): 24–27.
Weng CH, Lin MX, Yang YF. et al. The clinical analysis of infectious mononucleosis with hepatic lesion. Hebei Med 2005;11(6): 558–560.
About this article
Cite this article
Cao, Z., Zhao, Z. & Zhao, X. Effect of Compound Glycyrrhizin Injection on liver function and cellular immunity of children with infectious mononucleosis complicated liver impairment. Chin. J Integ. Med. 12, 268–272 (2006). https://doi.org/10.1007/s11655-006-0268-1
- infectious mononucleosis
- liver impairment
- T lymphocyte subsets
- Compound Glycyrrhizin Injection